Published in Lancet on June 19, 2004
A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med (2013) 5.52
Questioning an axiom: better prognosis for schizophrenia in the developing world? Schizophr Bull (2007) 3.24
Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ (2013) 3.06
Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev (2012) 2.54
Clozapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (2010) 2.13
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets (2006) 1.78
Differences in mortality and suicidal behaviour between treated and never-treated people with schizophrenia in rural China. Br J Psychiatry (2009) 1.55
Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis (2007) 1.51
Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion. Nat Med (2016) 1.39
Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev (2010) 1.38
Recovery and severe mental illness: description and analysis. Can J Psychiatry (2014) 1.37
Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks. Curr Top Med Chem (2013) 1.28
Association between SNPs and gene expression in multiple regions of the human brain. Transl Psychiatry (2012) 1.27
The relationship between anxiety disorders and suicide attempts: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Depress Anxiety (2010) 1.25
A dynamical systems hypothesis of schizophrenia. PLoS Comput Biol (2007) 1.25
Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice. PLoS One (2012) 1.21
Population-attributable fractions of Axis I and Axis II mental disorders for suicide attempts: findings from a representative sample of the adult, noninstitutionalized US population. Am J Public Health (2010) 1.20
A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia. Psychiatry (Edgmont) (2010) 1.18
Emerging empirical evidence on the ethics of schizophrenia research. Schizophr Bull (2005) 1.16
Dopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)-a suitable endophenotype of schizophrenia. Front Hum Neurosci (2013) 1.10
Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study. Schizophr Res (2011) 1.10
A behavioral weight-loss intervention for persons with serious mental illness in psychiatric rehabilitation centers. Int J Obes (Lond) (2010) 1.09
Cocaine-induced hyperactivity and sensitization are dependent on GSK3. Neuropharmacology (2009) 1.08
Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry (2013) 1.07
HLA-B maternal-fetal genotype matching increases risk of schizophrenia. Am J Hum Genet (2006) 1.04
Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: the ACHIEVE trial. BMC Psychiatry (2010) 1.03
Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Patient Prefer Adherence (2013) 1.01
Study of OH radicals in human serum blood of healthy individuals and those with pathological schizophrenia. Int J Mol Sci (2011) 0.96
A quantitative theory of the functions of the hippocampal CA3 network in memory. Front Cell Neurosci (2013) 0.96
Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention. Philos Trans R Soc Lond B Biol Sci (2008) 0.96
Association of PDE4B polymorphisms and schizophrenia in Northwestern Han Chinese. Hum Genet (2011) 0.94
Convergent evidence from multimodal imaging reveals amygdala abnormalities in schizophrenic patients and their first-degree relatives. PLoS One (2011) 0.93
Recovery centers for people with severe mental illness: a survey of programs. Community Ment Health J (2011) 0.93
Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry (2014) 0.91
Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease. Drug Discov Today (2013) 0.90
Quality of medical care for persons with serious mental illness: A comprehensive review. Schizophr Res (2015) 0.89
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Psychopharmacology (Berl) (2005) 0.88
Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia. Schizophr Bull (2010) 0.88
Recent advances in treating cognitive impairment in schizophrenia. Psychopharmacology (Berl) (2008) 0.87
Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice. Neuropsychopharmacology (2010) 0.87
Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats. Schizophr Res (2009) 0.87
Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis. Schizophr Res (2010) 0.86
Increased stathmin1 expression in the dentate gyrus of mice causes abnormal axonal arborizations. PLoS One (2010) 0.86
Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection. Schizophr Res Treatment (2012) 0.86
Pharmacokinetic-pharmacodynamic modeling of severity levels of extrapyramidal side effects with markov elements. CPT Pharmacometrics Syst Pharmacol (2012) 0.86
Schizophrenia and potentially preventable hospitalizations in the United States: a retrospective cross-sectional study. BMC Psychiatry (2013) 0.86
The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling. Psychopharmacology (Berl) (2013) 0.86
Tetrachloroethylene exposure and risk of schizophrenia: offspring of dry cleaners in a population birth cohort, preliminary findings. Schizophr Res (2006) 0.85
Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness. Gen Hosp Psychiatry (2015) 0.85
News media framing of serious mental illness and gun violence in the United States, 1997-2012. Am J Public Health (2014) 0.85
Parenting an adult child with bipolar disorder in later life. J Nerv Ment Dis (2009) 0.85
Therapeutic potential of metabotropic glutamate receptor modulators. Curr Neuropharmacol (2012) 0.85
Neurobiology of cognitive remediation therapy for schizophrenia: a systematic review. Front Psychiatry (2014) 0.84
Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice. Psychopharmacology (Berl) (2009) 0.84
The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents. Br J Pharmacol (2013) 0.84
Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia. J Biomed Biotechnol (2010) 0.84
Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial. Ther Adv Psychopharmacol (2011) 0.84
Effect of Rhesus D incompatibility on schizophrenia depends on offspring sex. Schizophr Res (2008) 0.83
Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance. J Cell Physiol (2012) 0.83
The neuroimmunology of schizophrenia. Clin Psychopharmacol Neurosci (2013) 0.83
Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. BMC Psychiatry (2012) 0.82
Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice. Neuropsychopharmacology (2012) 0.81
Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT). ACS Med Chem Lett (2015) 0.81
[Antipsychotic drug-induced changes in metabolism]. Wien Klin Wochenschr (2006) 0.80
Injury risk and severity in a sample of Maryland residents with serious mental illness. Inj Prev (2012) 0.80
Analysis of heart rate variability during auditory stimulation periods in patients with schizophrenia. J Clin Monit Comput (2014) 0.80
Evidence for an immune role on cognition in schizophrenia: a systematic review. Curr Neuropharmacol (2014) 0.80
Culture, stress and recovery from schizophrenia: lessons from the field for global mental health. Cult Med Psychiatry (2010) 0.80
Comparative Study on Serum Levels of 10 Trace Elements in Schizophrenia. PLoS One (2015) 0.80
Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies. Schizophr Res Treatment (2010) 0.79
Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study. BMC Psychiatry (2013) 0.79
First psychiatric hospitalizations in the US military: the National Collaborative Study of Early Psychosis and Suicide (NCSEPS). Psychol Med (2006) 0.79
Do research procedures pose relatively greater risk for healthy persons than for persons with schizophrenia? Schizophr Bull (2005) 0.79
A Role for Oxytocin in the Etiology and Treatment of Schizophrenia. Front Endocrinol (Lausanne) (2015) 0.79
Toward developmental models of psychiatric disorders in zebrafish. Front Neural Circuits (2013) 0.79
Prenatal protein malnutrition decreases KCNJ3 and 2DG activity in rat prefrontal cortex. Neuroscience (2014) 0.78
Altered functional connectivity links in neuroleptic-naïve and neuroleptic-treated patients with schizophrenia, and their relation to symptoms including volition. Neuroimage Clin (2014) 0.78
Schizophrenia. Lancet (2004) 0.78
The role of leptin in antipsychotic-induced weight gain: genetic and non-genetic factors. J Obes (2012) 0.78
Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China. Br J Psychiatry (2015) 0.78
Clinical correlates of parametric digit-symbol substitution test in schizophrenia. Asian J Psychiatr (2014) 0.78
Schizophrenia and Suicide Attempts: Findings from a Representative Community-Based Canadian Sample. Schizophr Res Treatment (2016) 0.78
Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population. PLoS One (2015) 0.77
The effect of verbalization strategy on Wisconsin Card Sorting Test performance in schizophrenic patients receiving classical or atypical antipsychotics. BMC Psychiatry (2006) 0.77
From pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl group. PLoS One (2014) 0.77
Cognitive training for schizophrenia in developing countries: a pilot trial in Brazil. Schizophr Res Treatment (2013) 0.77
Metacognitive training for schizophrenia: a systematic review. Shanghai Arch Psychiatry (2015) 0.77
Wealth Inequality and Mental Disability Among the Chinese Population: A Population Based Study. Int J Environ Res Public Health (2015) 0.77
Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning. Mol Psychiatry (2017) 0.76
Gene expression profiling in rodent models for schizophrenia. Curr Neuropharmacol (2010) 0.76
A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings. Int J Endocrinol (2015) 0.76
Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies. Neural Plast (2016) 0.76
Differential patterns of blood oxygenation in the prefrontal cortex between patients with methamphetamine-induced psychosis and schizophrenia. Sci Rep (2015) 0.76
Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm (Vienna) (2014) 0.76
Subjective burden and personal gains among older parents of adults with serious mental illness. Psychiatr Serv (2010) 0.76
Lack of effects of typical and atypical antipsychotics in DARPP-32 and NCS-1 levels in PC12 cells overexpressing NCS-1. J Negat Results Biomed (2010) 0.76
Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population. Neuropsychiatr Dis Treat (2015) 0.76
Changes in Prevalence and Socioeconomic Factors of Psychiatric Disability among Children in China from 1987-2006: A Population Based Survey. Int J Environ Res Public Health (2017) 0.75
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. Cochrane Database Syst Rev (2012) 0.75
A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry (2011) 5.21
The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone. Biol Psychiatry (2002) 2.70
Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am J Psychiatry (2012) 1.53
GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res (2004) 1.18
mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. J Neurosci Res (2005) 1.16
Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology (Berl) (2003) 1.06
Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity. Am J Psychiatry (2002) 1.00
Improving social cognition in schizophrenia: a pilot intervention combining computerized social cognition training with cognitive remediation. Schizophr Bull (2012) 0.98
RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem (2003) 0.96
Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophrenia. J Clin Exp Neuropsychol (2006) 0.91
Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients. Schizophr Res (2010) 0.89
Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder. Int J Neuropsychopharmacol (2005) 0.78
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study. Schizophr Res (2007) 0.77